Marcy l'Etoile, France - October 20, 2011.
- Sales:
- Up 5.2% at constant exchange rates
- Including 4% organic growth
- Robust 8% organic growth in clinical microbiology
- Double-digit organic growth continues in Asia-Pacific and Latin America
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2011.
Download
- Filename
- pr_biomerieux_sales_q3_2011.pdf
- Size
- 139 KB
- Format
- application/pdf